Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
HSIC 
Henry Schein Inc (HSIC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: HSIC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
16 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $73.23
1 Year Target Price $73.23
| 3 | Strong Buy |
| 4 | Buy |
| 8 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -25.94% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 7.69B USD | Price to earnings Ratio 20.25 | 1Y Target Price 73.23 |
Price to earnings Ratio 20.25 | 1Y Target Price 73.23 | ||
Volume (30-day avg) 16 | Beta 0.81 | 52 Weeks Range 60.56 - 82.49 | Updated Date 10/14/2025 |
52 Weeks Range 60.56 - 82.49 | Updated Date 10/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.05% | Operating Margin (TTM) 5.4% |
Management Effectiveness
Return on Assets (TTM) 4.3% | Return on Equity (TTM) 8.12% |
Valuation
Trailing PE 20.25 | Forward PE 12.69 | Enterprise Value 11220352319 | Price to Sales(TTM) 0.6 |
Enterprise Value 11220352319 | Price to Sales(TTM) 0.6 | ||
Enterprise Value to Revenue 0.88 | Enterprise Value to EBITDA 12.04 | Shares Outstanding 121268398 | Shares Floating 101950342 |
Shares Outstanding 121268398 | Shares Floating 101950342 | ||
Percent Insiders 0.87 | Percent Institutions 113.83 |
Upturn AI SWOT
Henry Schein Inc
Company Overview
History and Background
Henry Schein, Inc. was founded in 1932. Initially a drugstore in Queens, New York, it evolved into a dental supply company. Over the years, it expanded its offerings to include medical and animal health products, becoming a global distributor of healthcare products and services.
Core Business Areas
- Dental: Distribution of dental supplies, equipment, and technology solutions to dental practices and laboratories worldwide. This includes consumables, small equipment, large equipment, and practice management software.
- Medical: Distribution of medical supplies, equipment, and technology solutions to physician practices, hospitals, and other healthcare providers. This includes exam room supplies, diagnostic tests, vaccines, and point-of-care ultrasound systems.
- Animal Health: Distribution of animal health products, equipment, and services to veterinary practices. This includes pharmaceuticals, vaccines, diagnostic tests, and surgical instruments.
- Technology and Value-added Services: Services includes practice management software, financial services, and technology consulting to help clients operate more efficiently and effectively.
Leadership and Structure
Stanley M. Bergman serves as the Chairman of the Board and Chief Executive Officer. The organizational structure is based on geographic regions and business segments, with a corporate headquarters overseeing operations and strategic direction.
Top Products and Market Share
Key Offerings
- Dental Consumables: A wide range of dental consumables such as gloves, masks, disinfectants, impression materials, and restorative materials. Competitors include Patterson Dental, Benco Dental, and Envista Holdings. Market share information is not consistently broken down by specific product category, but Henry Schein is a leading distributor in this area.
- Dental Equipment: Dental chairs, X-ray machines, digital imaging systems, and CAD/CAM systems. Competitors include Planmeca, Dentsply Sirona, and Carestream Dental. Revenue from the technology and equipment category represents a significant portion of total sales.
- Practice Management Software: Software solutions for appointment scheduling, patient record management, billing, and other administrative tasks. Competitors include CareStack, Planet DDS, and Eaglesoft (part of Patterson Dental). Market share information is not publicly available.
- Medical Supplies: Exam room supplies, diagnostic tests, vaccines, and pharmaceuticals for physicians. Competitors include McKesson, Cardinal Health, and Medline Industries. Market share information is not consistently broken down by specific product category, but Henry Schein is a leading distributor in this area.
Market Dynamics
Industry Overview
The healthcare distribution industry is characterized by consolidation, technological advancements, and increasing regulatory scrutiny. The demand for healthcare products and services is driven by an aging population, increasing prevalence of chronic diseases, and growing awareness of preventive care.
Positioning
Henry Schein is a leading global distributor of healthcare products and services, with a strong presence in the dental, medical, and animal health markets. Its competitive advantages include its broad product portfolio, extensive distribution network, and value-added services.
Total Addressable Market (TAM)
The global healthcare distribution market is estimated to be worth billions of dollars. Henry Schein is positioned to capture a significant portion of this TAM by offering a comprehensive range of products and services to healthcare providers.
Upturn SWOT Analysis
Strengths
- Global distribution network
- Broad product portfolio
- Strong relationships with suppliers
- Value-added services
- Established brand reputation
Weaknesses
- Dependence on key suppliers
- Exposure to economic cycles
- Integration risks from acquisitions
- Potential for pricing pressure
Opportunities
- Expanding into emerging markets
- Increasing demand for digital healthcare solutions
- Growing prevalence of chronic diseases
- Consolidation in the healthcare industry
- Growing animal health market
Threats
- Increased competition
- Regulatory changes
- Supply chain disruptions
- Fluctuations in foreign exchange rates
- Economic downturns
Competitors and Market Share
Key Competitors
- MCK
- CAH
- PDCO
Competitive Landscape
Henry Schein is a leading player in the healthcare distribution market, with a strong competitive position. Its advantages include its broad product portfolio, global distribution network, and value-added services. Disadvantages include exposure to economic cycles and dependence on key suppliers.
Major Acquisitions
NDC, Inc.
- Year: 2014
- Acquisition Price (USD millions): 844
- Strategic Rationale: Expanded animal health business and strengthened market position.
Growth Trajectory and Initiatives
Historical Growth: Henry Schein has experienced steady growth through organic expansion and strategic acquisitions.
Future Projections: Analyst estimates suggest continued growth in revenue and earnings per share.
Recent Initiatives: Recent initiatives include investments in digital healthcare solutions, expansion into emerging markets, and acquisitions of complementary businesses.
Summary
Henry Schein is a strong company in the healthcare distribution market, supported by a global network and diverse product offerings. Its consistent revenue growth indicates effective strategies. The company needs to carefully manage its reliance on key suppliers and exposure to economic downturns to maintain its competitive edge.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (10K, 10Q)
- Investor presentations
- Analyst reports
- Industry publications
- Company Website
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Henry Schein Inc
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1995-11-03 | Executive Chairman & CEO Mr. Stanley M. Bergman CPA | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 25000 | Website https://www.henryschein.com |
Full time employees 25000 | Website https://www.henryschein.com | ||
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.